Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Trading Update

5 Jan 2017 07:00

RNS Number : 3773T
Persimmon PLC
05 January 2017
 

 

 

TRADING UPDATE - 5 JANUARY 2017

 

 

Persimmon plc announces the following update ahead of its Final Results for the year ended 31 December 2016, which will be released on 27 February 2017.

 

Revenues for 2016 of £3.14bn were 8% higher than the prior year (2015: £2.90bn) with legal completion volumes increasing by 599 new homes to 15,171 (2015: 14,572). The Group's average selling price increased by 4% to c. £206,700 (2015: £199,127).

 

Sales reservations through the autumn season were strong with healthy customer demand for new homes. Buying a new-build home remains a compelling choice supported by competitive mortgage offers which continue to make a new home purchase very affordable. The Group's private sales rate for the second half of the year was 15% ahead of the prior year and second half legal completion volumes of 7,933 were 695 stronger than for the first half of the year (H1: 7,238).

 

We have continued to focus on disciplined high quality growth to achieve sustainable market share in our regional markets. The two new house building businesses we opened at the start of 2016 based in Perth, Scotland and Launceston, Cornwall have made good progress delivering over 650 new homes in their first year of operation. On 2 January 2017 we launched a further new business based in Mansfield, north of Nottingham, to support the delivery of increased volumes of new homes in this regional market. The value of our forward sales at 31 December 2016 of c. £1,230m is 12% ahead of the prior year (2015: £1,103m).

 

The Group successfully opened 255 new development sites across the UK during the year and is building on all sites which have an implementable planning consent. We expect our gross margin in the second half will have improved further due to a combination of the continued reduction in our land cost recoveries associated with opening new sites, and the continued strong control over development costs.

 

During the year we acquired c. 18,700 plots of new land in 83 locations with good deferred terms. We continue to see good opportunities to acquire additional land whilst remaining mindful of the risks associated with the uncertainty arising from the UK's decision to leave the EU. We continue to work hard to bring forward opportunities from the Group's strategic land portfolio which will add to the quality of the Group's asset platform. We expect local authorities to continue to progress their plans to support growth in housing delivery in line with the National Planning Policy Framework.

 

The Group held cash balances of c. £913m at 31 December 2016 (2015: £570m).

 

We will give a further update on our assessment of the housing market over the early weeks of 2017 when we announce our results for the year ended 31 December 2016 on Monday 27 February 2017.

 

 

Please Note

There will be a call for analysts at 09.00 GMT today. Please use the dial-in details below:

 

Telephone number:

+44(0) 330 336 9105

Conference code:

Persimmon

 

An audiocast of the call will be available on www.corporate.persimmonhomes.com 

 

 

For further information please contact:

 

 

Jeff Fairburn

Group Chief Executive

Mike Killoran

Group Finance Director

 

 

Persimmon Plc

Tel: +44(0)1904 642199

 

 

 

 

Simon Rigby

 

Kevin Smith

 

Jos Bieneman

 

 

 

Citigate Dewe Rogerson

Tel: +44(0) 2076 389571

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFMGGMNDVGNZM
Date   Source Headline
8th Dec 20203:50 pmRNSDirector/PDMR Shareholding
1st Dec 20203:22 pmRNSBlock listing Interim Review
1st Dec 20203:01 pmRNSTotal Voting Rights
25th Nov 202011:50 amRNSAdditional Listing
10th Nov 20207:00 amRNSThird Quarter Trading Statement
2nd Nov 20203:11 pmRNSTotal Voting Rights
27th Oct 20203:37 pmRNSAdditional Listing
16th Oct 202012:46 pmRNSGrant of SAYE Option
29th Sep 202012:27 pmRNSDirector/PDMR Shareholding
8th Sep 202010:25 amRNSNew Chief Executive Officer Start Date
1st Sep 20202:00 pmRNSTotal Voting Rights
28th Aug 20202:02 pmRNSDirector/PDMR Shareholding
26th Aug 20207:44 amRNSPersimmon Plc (PSN) - Additional Listing
19th Aug 20207:02 amRNSUpdate on Chief Executive Officer Appointment
18th Aug 20207:00 amRNSHalf Year Results
20th Jul 20201:49 pmRNSDirector/PDMR Shareholding
9th Jul 20207:00 amRNSTrading Update
1st Jul 202012:42 pmRNSTotal Voting Rights
29th Jun 20204:58 pmRNSAppointment of CEO
24th Jun 20207:00 amRNSAppointment of new Chief Executive Officer
8th Jun 20204:17 pmRNSDirectorate Change
5th Jun 202010:00 amRNSDirector/PDMR Shareholding
1st Jun 20202:05 pmRNSBlock listing Interim Review
1st Jun 20201:13 pmRNSTotal Voting Rights
26th May 20202:28 pmRNSDirector/PDMR Shareholding
20th May 20208:40 amRNSDirector Declaration
14th May 20207:00 amRNSCOVID-19 Update
1st May 20201:56 pmRNSTotal Voting Rights
29th Apr 20203:34 pmRNSResult of AGM
29th Apr 20207:01 amRNSBoard Change
29th Apr 20207:00 amRNSTrading Update
27th Apr 20204:32 pmRNSDisclosure of rights attached to equity shares
24th Apr 20207:00 amRNSCOVID-19 Update
3rd Apr 20209:16 amRNSDirector Declaration
2nd Apr 20206:14 pmRNSFurther Update on Covid-19 – Board Remuneration
1st Apr 20209:51 amRNSTotal Voting Rights
25th Mar 20207:00 amRNSCovid-19, Capital Return Plan and AGM Updates
17th Mar 20203:42 pmRNSAnnual Financial Report
16th Mar 20207:00 amRNSAppointment of Joint Corporate Broker
5th Mar 20204:47 pmRNSDirector/PDMR Shareholding
2nd Mar 202011:05 amRNSTotal Voting Rights
27th Feb 20207:00 amRNSCEO Succession
27th Feb 20207:00 amRNSFinal Results
17th Feb 20207:00 amRNSBoard Change
3rd Feb 202012:00 pmRNSTotal Voting Rights
15th Jan 20207:02 amRNSBoard Change
15th Jan 20207:00 amRNSTrading Update
2nd Jan 202011:01 amRNSTotal Voting Rights
2nd Dec 201912:45 pmRNSBlock listing Interim Review
18th Nov 20193:48 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.